Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The compounds tested could potentially treat hair loss and alopecia.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Researchers made two new compounds that could be used for medicine.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

A new method to make finasteride for hair loss treatment was developed.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Gut microbes significantly affect brain steroid levels.